Search clinical trials for: VAL-083, Dianhydrogalactitol

Total 2397 results

DelMar Pharmaceuticals, Inc.

Withdrawn

A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer (REPROVe)

Ovarian Cancer

United States
Kintara Therapeutics, Inc.

Active, not recruiting

Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting

Glioma | Glioblastoma | Brain Cancer | Glioblastoma Multiforme | GBM

United States
Kintara Therapeutics, Inc.
Sun Yat-sen University

Active, not recruiting

Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression

Glioma | Glioblastoma | Brain Cancer | Glioblastoma Multiforme | GBM

China
DelMar Pharmaceuticals, Inc.

Completed

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

Glioma | Glioblastoma | Brain Cancer | Glioblastoma Multiforme | GBM

United States
Kintara Therapeutics, Inc.

No longer available

Expanded Access to VAL-083

Cancer
DelMar Pharmaceuticals, Inc.

Terminated

VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM (STAR-3)

Glioma | Glioblastoma | Brain Cancer | Glioblastoma Multiforme | GBM

United States
Global Coalition for Adaptive Research
Bayer; Kazia Therapeutics Limited; Biohaven Pharmaceuticals, Inc.; Kintara Therapeutics... and other collaborators

Recruiting

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (GBM AGILE)

Glioblastoma

United States, France, Germany, Canada, Australia, Switzerland
Sound Surgical Technologies, LLC.

Completed

VASER-Assisted Lipoplasty Compared With Suction-Assisted Lipoplasty (Contra-Lateral)

Healthy

United States
Alcon Research

Withdrawn

Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis
Sun Pharma Advanced Research Company Limited

Completed

Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer

Breast Cancer and Ovarian Cancer
Alcon Research

Completed

Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa

Acute Otitis Externa
Alcon Research

Completed

Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa

Acute Otitis Externa
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)

Facioscapulohumeral Muscular Dystrophy

United States, Spain, Canada
Parasail, LLC

Available

Intravenous VAL-1221 Lafora Expanded Access Protocol (LEAP)

Lafora Disease
University of Colorado, Denver
National Institute of Mental Health (NIMH)

Terminated

Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects (AVL3288)

Schizophrenia

United States
Acceleron Pharma Inc. (a wholly owned subsidiary...

Completed

Phase 1 Study of ACE-083 in Healthy Subjects

Musculoskeletal Diseases

United States
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)

Charcot-Marie-Tooth Disease | Facioscapulohumeral Muscular Dystrophy

United States, Spain, Canada
University of California, Davis
Bill and Melinda Gates Foundation; Penn State University; Newcastle University; Helen Keller International and other collaborators

Completed

Vitamin A Status and Risk of Excessive Vitamin A Intake Among Urban Filipino Children (GloVitAS-P)

Vitamin A Status

Philippines
Valerion Therapeutics, LLC

Terminated

VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease

Pompe Disease

United States, United Kingdom
Idorsia Pharmaceuticals Ltd.

Completed

First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders

Healthy Subjects

Germany
Peking Union Medical College Hospital

Completed

177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

China
Medical University of Vienna

Unknown

Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG

Coronary Artery Disease | Aorto-coronary Bypass Grafting

Austria
ModernaTX, Inc.

Completed

Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects

Influenza

Germany
ModernaTX, Inc.
Defense Advanced Research Projects Agency

Completed

Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy Subjects

Chikungunya Virus

United States
ModernaTX, Inc.

Completed

Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects

Influenza

United States
Merck Sharp & Dohme LLC

Completed

Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C

Chronic Hepatitis C

United States
A. Vogel AG

Completed

Echinacea Safety Study

Infections

United Kingdom
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth Disease

United States
Ataturk Training and Research Hospital

Completed

Effects of Nasal Septal Surgery on Sleep Quality, Daytime and Dream Anxiety

Nasal Septal Deviation

Turkey
Dupont Applied Biosciences

Unknown

Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors

HIV Infections

United States
David Brienza

Completed

An RCT on Support Surfaces for Pressure Ulcer Prevention

Pressure Ulcer | Pressure Injury

United States
Celgene

Completed

Safety and Pharmacokinetics of AVL-292 Following Multiple Doses and the Effect of Food on the Single-dose Pharmacokinetics of AVL-292

Healthy

United States
Kessler Foundation

Unknown

Pairing Functional Electrical Stimulation (FES) and Volitional Effort Training Promotes Neuroplasticity and Motor Gain

Stroke | Drop Foot
University Hospital, Grenoble

Completed

Multicenter Trial Assessing an Innovative VAS of Pain Among Deaf People (EVA_SOURD)

Deafness | Visual Analog Pain Scale

France
St. Luke's-Roosevelt Hospital Center
Kinetic Concepts, Inc.

Completed

V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds

Venous Stasis Ulcers | Lower Extremity Wound Infected

United States
Photocure

Completed

A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.

Cervical Dysplasia

Germany, Norway
Joint Authority for Päijät-Häme Social and Health...
Helsinki University Central Hospital

Completed

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

Actinic Keratoses

Finland
University of Maryland, Baltimore
National Center for Complementary and Integrative Health (NCCIH)

Terminated

Safety of VSL#3 in Adult Asthmatics

Asthma

United States
Dayton Children's Hospital
National Institutes of Health (NIH)

Terminated

The Use of VSL#3 in Irritable Bowel Syndrome in Children (VSL#3)

Irritable Bowel Syndrome

United States
Masonic Cancer Center, University of Minnesota

Completed

Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT

Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML)

United States
Medela AG

Completed

Impact of Breast Shield Designs on Dynamics of Breast Pumping (BSD)

Lactation

Switzerland
University of Missouri-Columbia
University of Alabama at Birmingham; Medical College of Wisconsin; University...

Completed

Role of Vacuum Assisted Closure (VAC) Device in Postoperative Management of Pelvic and Acetabular Fractures

Hip Fractures | Pelvic Fractures | Acetabular Fractures

United States
Policlinico Hospital

Unknown

Impact of Probiotic Preparation VSL#3 on Infants Colics

Infant Colics

Italy
NewLink Genetics Corporation

Terminated

Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
ReliantHeart Inc.

Terminated

Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation

Heart Failure | Congestive Heart Failure | Cardiac Failure | Heart Failure, Left-sided

United States
Kaplan-Harzfeld Medical Center

Completed

Probiotics and Hospital Outcome in the Elderly (PROAGE)

Constipation | Diarrhea
Novo Nordisk A/S

Completed

A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With Obesity

Obesity | Overweight

United States
HAL Allergy

Completed

HAL-MPE1 First-in-human (HAL-MPE1/0043)

Peanut Allergy

Denmark
Ministerio de Salud de Ciudad Autónoma de Buenos...

Active, not recruiting

Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.

COVID-19 Vaccines

Argentina
Biocad

Completed

An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis (BCD-085-7)

Moderate to Severe Plaque Psoriasis

Russian Federation

Search clinical trials for: VAL-083, Dianhydrogalactitol

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations